分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts

Li Xin, Yong Tuying, Wei Zhaohan, Bie Nana, Zhang Xiaoqiong, Zhan Guiting, Li Jianye, Qin Jiaqi, Yu Jingjing, Zhang Bixiang, Gan Lu, Yang Xiangliang

Journal:Nature Communications

IF:17.69

DOI:10.1038/s41467-022-30306-7

PMID:35589680

Published:2022-05-19

research field:肿瘤学分子生物学基因治疗纳米医学眼科学

Abstract

Insufficient tumor accumulation and distribution of photosensitizers as well as low antitumor immunity severely restrict the therapeutic efficacy of photothermal therapy (PTT). Cancer-associated fibroblasts (CAFs) play a key role in tumor extracellular matrix (ECM) remodeling and immune evasion. Reshaping tumor microenvironment via CAF regulation might provide a potential approach for complete tumor elimination in combination with PTT. Here, tumor cell-derived microparticles co-delivering calcipotriol and Indocyanine green (Cal/ICG@MPs) are developed to modulate CAFs for improved PTT efficacy. Cal/ICG@MPs efficiently target tumor tissues and regulate CAFs to reduce tumor ECM, resulting in enhanced tumor accumulation and penetration of ICG to generate strong PTT efficacy and activate CD8 + T cell-mediated antitumor immunity. In addition, Cal/ICG@MPs-triggered CAF regulation enhances tumor infiltration of CD8 + T cells and ameliorates CAF-induced antigen-mediated activation-induced cell death of tumor-specific CD8 + T cells in response to PTT, eliciting long-term antitumor immune memory to inhibit tumor recurrence and metastasis. Our results support Cal/ICG@MPs as a promising drug to improve PTT efficacy in cancer treatment.

本文使用的Yeasen产品

购物车
客服
转染试用